glp 1 agonist and depression Transformation 2.0: The GLP-1 RAs as Psychiatric Medications? Mechanisms by which GLP-1 agonists

Epicardial fat expansion in diabetic and obese patients with heart failure and preserved ejection fraction-A specific HFpEF phenotype

However, the financial impact of the reported decrease in cardiovascular events has not yet been established (39)

14 These AEs can significantly impact a patients quality of life, leading to decreased adherence, limitation of dose escalations, and, in some cases, treatment discontinuation

A diet with limited carbohydrates and saturated fat and enriched with high fiber and unsaturated fats, such as the Mediterranean diet, should be encouraged due to the cardiovascular benefits that are seen

In phase III trials, these agents have demonstrated an average A1C decrease of about 0.5% when administered as monotherapy

Lidocaine Patches or Creams : (Generic Aspercreme) Perfect for numbing the specific, localized area of your weekly injection site to reduce bruising and soreness